India Supreme Court Warns Against Tinkering With Essential-Drug Policy
This article was originally published in PharmAsia News
Executive Summary
India's Supreme Court cautioned the government against making any changes in the pricing mechanism for controlling the costs of the nation's 438 essential medicines while giving it until Oct. 9 to name the drugs on the list.